PROVO, Utah--(BUSINESS WIRE)--GeNOsys (generated nitric oxide systems) Inc. (OTCBB:GNYS), a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems, announces the Company’s Board of Directors’ Chairman, Mr. Clark Mower, and Medical Director, Steven Minton, M.D., presented to a group of investment fund managers and investor relations firms in New York City on Wednesday, July 30 and Thursday, July 31. Company management presented information related to GeNOsys’ successful research and development of its patented and patent pending generated Nitric Oxide technologies.
